GSK's experimental IL-5 inhibitor depemokimab has shown its potential in a pair of phase 3 trials in patients with chronic rhinosinusitis with nasal polyps (CRSwNP). The company said this morning ...

Dr. Albritton is a resident physician and Dr. Kingdom is Assistant Professor in the Department of Otolaryngology at Emory University School of Medicine, Atlanta, Ga. Albritton FD, Kingdom TT.

Along with asthma, the antibody could have potential in other inflammatory diseases, including chronic rhinosinusitis with nasal polyps, chronic obstructive pulmonary disorder (COPD), and chronic ...

After hours: November 27 at 7:17 PM EST Loading Chart for HE ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

In History looks at the dilemma that faced Ashe, when, after years of secrecy, he once again became a groundbreaking campaigner. In April 1992, Arthur Ashe made his way into a packed conference ...